US OptionsDetailed Quotes
GDRX240517P12500
- 4.92
- 0.000.00%
15min DelayClose May 17 15:31 ET
0.00High0.00Low
0.00Open4.92Pre Close0 Volume0 Open Interest12.50Strike Price0.00Turnover0.00%IV5.28%PremiumMay 17, 2024Expiry Date5.30Intrinsic Value100Multiplier-5DDays to Expiry0.00Time Value100Contract SizeAmericanOptions Type--Delta--Gamma1.46Leverage Ratio--Theta--Rho--Eff Leverage--Vega
GoodRx Stock Discussion
Sign in to post a comment
The market simmered from all-time highs Thursday morning to close lower with 7000 decliners compared to 5900 advancing equities. Still, the $Dow Jones Industrial Average (.DJI.US)$ burst through 40k for the first time, and traded -0.1% at the time of the closing bell.
The $S&P 500 Index (.SPX.US)$ fell 0.21% after hitting an all-time high close Wednesday and setting a new record Thursday morning at 5325.46. The$Nasdaq Composite Index (.IXIC.US)$fe...
The $S&P 500 Index (.SPX.US)$ fell 0.21% after hitting an all-time high close Wednesday and setting a new record Thursday morning at 5325.46. The$Nasdaq Composite Index (.IXIC.US)$fe...
18
1
Morning Movers
Gapping up
$Canada Goose(GOOS.US$ surged over 12% after surpassing sales and earnings estimates for its fiscal fourth quarter and indicated a key profit margin metric would grow by approximately 100 basis points this year compared to fiscal 2024.
$Walmart(WMT.US$ 's stock increased by 4.7% post-reporting adjusted first-quarter earnings of 60 cents per share, eclipsing the expected 52 cents, with revenue reaching ...
Gapping up
$Canada Goose(GOOS.US$ surged over 12% after surpassing sales and earnings estimates for its fiscal fourth quarter and indicated a key profit margin metric would grow by approximately 100 basis points this year compared to fiscal 2024.
$Walmart(WMT.US$ 's stock increased by 4.7% post-reporting adjusted first-quarter earnings of 60 cents per share, eclipsing the expected 52 cents, with revenue reaching ...
22
3
Meme stocks are Pulling back after a two day rush! Meanwhile, the S&P 500 broke 5,300 and joined the Nasdaq and Dow Jones ending the day at new record highs after the CPI print.
Just after 4 PM EST, the $S&P 500 Index traded up 1.17% past an all time high. The $Nasdaq Composite Index opened, setting an all-time closing high, and kept up a 1.40% climb to finish the day at 16,742.39.
The $Dow Jones Industrial Average(.DJI.US$ reached a r...
Just after 4 PM EST, the $S&P 500 Index traded up 1.17% past an all time high. The $Nasdaq Composite Index opened, setting an all-time closing high, and kept up a 1.40% climb to finish the day at 16,742.39.
The $Dow Jones Industrial Average(.DJI.US$ reached a r...
26
4
$GoodRx(GDRX.US$ gonna sell slivers lakes stake and kill the business.. great short
GoodRx Holdings' ROCE trend is concerning. Despite reinvestment in its business, shrinking returns and a significant stock price drop hint at a lack of multi-bagger potential.
RECAP
US Stocks Retreat After Rallying in 2023
US stocks pulled back on the first trading day of the year, locking gains posted in 2023, as the Magnificent Seven stocks retreated.
A Bloomberg gauge of the seven stocks declined 1.7%, weighing on the S&P 500 and the Nasdaq that are heavily weighted to the tech giants. The $Nasdaq Composite Index(.IXIC.US$ fell 1.6% to close at 14,765.94, its biggest daily decline since October. The $S&P 500 Index(.SPX.US$ slipped 0...
US Stocks Retreat After Rallying in 2023
US stocks pulled back on the first trading day of the year, locking gains posted in 2023, as the Magnificent Seven stocks retreated.
A Bloomberg gauge of the seven stocks declined 1.7%, weighing on the S&P 500 and the Nasdaq that are heavily weighted to the tech giants. The $Nasdaq Composite Index(.IXIC.US$ fell 1.6% to close at 14,765.94, its biggest daily decline since October. The $S&P 500 Index(.SPX.US$ slipped 0...
36
2
Concern arises over GoodRx Holdings' high P/S ratio as future revenue projections seem insufficient to maintain positive evaluation. Unless significant revenue improvements occur, high P/S values likely unsustainable.
$GoodRx(GDRX.US$ fell Tuesday after raising 13% last week. The drop followed $CVS Health(CVS.US$ investor day. The firm relased 2024 revenue guidance Tuesday morning, announcing a competitive prescription drug product called CostVantage, and a second program called TrueCost.
2
Stock is near 52 week low. large block purchases are being made on this dip still might have room to be lower. going to take position on the stock due to revenue and brand name. if there is any kind of recession in the near future the stock will be back up to its high due to individuals looking for the best options to pay for their prescriptions.
good luck investing 😸
good luck investing 😸
No comment yet
Tan Chin Seng klang : must buy more apples and Nvidia